FAAM-EUROBAT 2024 Concludes with Groundbreaking Advances in Food Allergy and Anaphylaxis Research
12. Dezember 2024 12:37 ET
|
European Academy of Allergy and Clinical Immunology
ATHENS, Greece, Dec. 12, 2024 (GLOBE NEWSWIRE) -- FAAM-EUROBAT 2024, held from 21-23 November at the InterContinental Athenaeum Athens, brought over 550 attendees from over 25 countries to share...
EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024
13. November 2024 05:43 ET
|
European Academy of Allergy and Clinical Immunology
On 21 November 2024, during the opening day of EAACI FAAM-EUROBAT 2024 in Athens, Greece, EAACI proudly launches World Anaphylaxis Day. Join us!
Insignis Therapeutics Receives Positive FDA Feedback on IN-001 Clinical Program for Needle-Free Anaphylaxis Treatment
05. November 2024 08:00 ET
|
Insignis Therapeutics, Inc.
Insignis Therapeutics advances IN-001, a needle-free anaphylaxis treatment, following FDA’s positive feedback and Fast Track designation.
Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis
07. Oktober 2024 08:00 ET
|
Insignis Therapeutics, Inc.
Insignis' Phase 1 trial shows IN-001 spray quickly reaches target epinephrine levels, sustained for 2 hours, offering a reliable needle-free alternative.
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
13. August 2024 07:30 ET
|
Insignis Therapeutics, Inc.
Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
Safer Skies Ahead: Congress Approves Legislation Requiring Updates to Airline Emergency Medical Kits
15. Mai 2024 14:59 ET
|
Asthma and Allergy Foundation of America
Washington, DC, May 15, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is celebrating Congressional action that could lead to safer skies for travelers with potentially...
Maryland Becomes Fourth State to Enact Elijah’s Law to Protect Kids with Food Allergies
26. April 2024 12:06 ET
|
Asthma and Allergy Foundation of America
Washington, D.C., April 26, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) celebrates the signing of Elijah’s Law in Maryland. The legislation, passed by the Maryland...
Global Skin Allergy Testing Market Report 2024-2028 with Analysis of Companies' Market Shares, Proprietary Technologies, Alliances and Patents
24. April 2024 06:14 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Global Skin Allergy Testing Market" report has been added to ResearchAndMarkets.com's offering.The global market for skin allergy testing is expected...
Auto-Injectors Market revenue to surpass USD 33 Billion by 2036, says Research Nester
21. Februar 2024 07:00 ET
|
Research Nester
New York , Feb. 21, 2024 (GLOBE NEWSWIRE) -- The global auto-injectors market size is predicted to expand at 17% CAGR between 2024 and 2036. The market is projected to garner a revenue of USD 33...
AAFA Statement on Uber Eats Super Bowl Ad
08. Februar 2024 15:20 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) issued the following statement which may be attributed to Kenneth Mendez, president and CEO: ...